查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1946644

2026年全球肿瘤医疗器材市场报告

Oncology Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肿瘤医疗器材市场发展迅速，预计将从2025年的1,777.2亿美元成长到2026年的2,101.5亿美元，复合年增长率达18.2%。过去几年的成长可归因于全球癌症发生率上升、医院肿瘤科扩建、对早期诊断技术的需求不断增长、先进诊断影像系统的广泛应用以及人们对癌症筛检计画的意识提升等因素。

预计未来几年肿瘤治疗设备市场规模将快速成长，到2030年将达到3,972.7亿美元，复合年增长率（CAGR）为17.3%。预测期内的成长将主要受以下因素驱动：个人化癌症治疗设备的普及、肿瘤基础设施投资的增加、门诊癌症治疗设施的扩张、人工智慧驱动的诊断工具的广泛应用以及对精准肿瘤解决方案的日益重视。预测期内的关键趋势包括：先进癌症诊断设备的普及、影像引导肿瘤治疗的广泛应用、微创癌症治疗工具的日益整合、精准放射治疗设备的扩展以及对早期癌症检测的日益重视。

预计未来几年，化疗需求的成长将推动肿瘤医疗器材市场的扩张。化疗是一种癌症治疗方法，它使用强效药物来清除快速分裂的癌细胞，从而减缓或阻止肿瘤的生长和扩散。全球癌症发生率的上升推动了化疗需求的增长，而不断增加的癌症诊断病例也促使人们需要针对各种癌症类型和阶段提供有效且广泛可用的治疗方法。肿瘤医疗器材透过实现更安全、更精准的药物输送和监测来辅助化疗，从而提高治疗效果和患者预后。例如，根据美国联邦癌症研究机构－国家癌症研究所（NCI）的数据，预计到2025年1月，美国新增癌症病例将达到204万例，高于2023年的196万例。这支撑了对化疗输送系统日益增长的需求。因此，化疗需求的成长正在促进肿瘤医疗器材市场的成长。

肿瘤医疗器材市场的主要企业致力于开发先进的、精准的解决方案，旨在提高治疗精度、病人安全性和临床工作流程效率。这些创新技术专注于微创技术、改进的可视化和即时治疗优化，从而支持多种癌症类型的成功治疗。例如，2025年4月，总部位于德国的医疗科技公司蔡司（Zeiss）的INTRABEAM 700系统获得了FDA 510(k)许可。 INTRABEAM 700系统是一款新一代机器人辅助术中放射治疗（IORT）平台，用于神经肿瘤和乳癌手术中的标靶放射治疗。该系统具有更高的精度、优化的符合人体工学的设计以及与手术流程的更佳集成，使临床医生能够在手术过程中进行局部放射治疗，同时减少周围正常组织的辐射暴露。 INTRABEAM 700整合了先进的成像、机器人技术和治疗计划功能，提高了治疗精度，加快了临床决策速度，并支持了肿瘤治疗行业向以患者为中心的技术先进型肿瘤治疗模式的转型。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球肿瘤医疗器材市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 先进癌症诊断设备的普及应用日益广泛
    • 扩大影像导引癌症治疗方法的应用
    • 微创癌症治疗工具整合的进展
    • 精密放射治疗设备的扩建
    • 人们越来越关注癌症早期检测

第五章 终端用户产业市场分析

  • 医院
  • 癌症治疗中心
  • 肿瘤诊所
  • 癌症研究所
  • 诊断影像中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球肿瘤医疗器材市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球肿瘤医疗器材市场规模、对比及成长率分析
  • 全球肿瘤医疗器材市场表现：规模与成长，2020-2025年
  • 全球肿瘤医疗器材市场预测：规模与成长，2025-2030年，2035年

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依设备类型
  • 近距离放射治疗装置、内视镜装置
  • 透过治疗
  • 化疗、荷尔蒙疗法、生物疗法/免疫疗法、放射线治疗
  • 最终用户
  • 医院、癌症研究机构和其他最终用户
  • 按类型细分：近距离放射治疗设备
  • 后荷机（高剂量率 (HDR) 和低剂量率 (LDR)）、施药器、种子和配件
  • 按类型细分：内视镜设备
  • 内视镜（软式、硬式、胶囊式）、内视镜超音波系统、内视镜附件

第十章 区域与国家分析

  • 全球肿瘤医疗器材市场：区域表现及预测，2020-2025年、2025-2030年及2035年
  • 全球肿瘤医疗器材市场：国家、绩效及预测，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 孟加拉国市场

第十九章 泰国市场

第二十章 越南市场

第21章 马来西亚市场

第22章 新加坡市场

第23章：菲律宾市场

第二十四章 香港市场

第25章：纽西兰市场

第二十六章 台湾市场

第27章 东南亚市场

第28章 西欧市场

第29章英国市场

第三十章：德国市场

第31章：法国市场

第32章：义大利市场

第33章：西班牙市场

第34章：奥地利市场

第35章：比利时市场

第三十六章：丹麦市场

第37章 芬兰市场

第38章：爱尔兰市场

第39章：荷兰市场

第四十章：挪威市场

第四十一章：葡萄牙市场

第42章：瑞典市场

第42章 瑞士市场

第43章 东欧市场

第四十四章：俄罗斯市场

第45章：捷克市场

第四十六章：波兰市场

第四十七章：罗马尼亚市场

第四十八章：乌克兰市场

第49章 北美市场

第五十章：美国市场

第51章 加拿大市场

第五十二章：墨西哥市场

第五十三章 南美洲市场

第五十四章：巴西市场

第55章 智利市场

第五十六章：阿根廷市场

第五十七章：哥伦比亚市场

第五十八章 秘鲁市场

第五十九章 中东市场

第六十章：沙乌地阿拉伯市场

第61章：以色列市场

第62章 伊朗市场

第63章 土耳其市场

第64章：阿联酋市场

第65章：非洲市场

第66章 埃及市场

第六十七章：尼日利亚市场

第68章 南非市场

第69章 市场监理与投资环境

第七十章：竞争格局与公司概况

  • 肿瘤医疗器材市场：竞争格局及市场占有率（2024年）
  • 肿瘤医疗器材市场：公司估值矩阵
  • 肿瘤医疗器材市场：公司概况
    • Eckert & Ziegler BEBIG GmbH
    • Oncura Inc.
    • GE Healthcare
    • Medtronic plc
    • Varian Medical Systems Inc.

第71章：其他领先和创新企业

  • Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer

第72章：全球市场竞争基准分析与仪錶板

第73章：重大併购

第74章：高潜力市场国家、细分市场与策略

  • 2030年肿瘤医疗器材市场：蕴藏新机会的国家
  • 2030年肿瘤医疗器材市场：新兴细分市场机会
  • 2030年肿瘤医疗器材市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第75章附录

简介目录
Product Code: ME2MODEV04_G26Q1

Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.

The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.

Tariffs are influencing the oncology devices market by increasing costs of imported imaging systems, radiation therapy equipment, endoscopic devices, precision components, and electronic subsystems used in cancer diagnosis and treatment. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end oncology equipment, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital investment requirements and slowing technology upgrades. However, they are also encouraging domestic manufacturing, localized assembly of oncology systems, and innovation in cost-efficient cancer care technologies.

The oncology devices market research report is one of a series of new reports from The Business Research Company that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology devices market size has grown rapidly in recent years. It will grow from $177.72 billion in 2025 to $210.15 billion in 2026 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of hospital oncology departments, growing demand for early diagnosis technologies, availability of advanced imaging systems, rising awareness of cancer screening programs.

The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $397.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, expansion of outpatient cancer treatment facilities, growing use of AI-driven diagnostic tools, increasing focus on precision oncology solutions. Major trends in the forecast period include increasing adoption of advanced cancer diagnostic devices, rising use of image-guided oncology therapies, growing integration of minimally invasive cancer treatment tools, expansion of precision radiation therapy equipment, enhanced focus on early cancer detection.

The growing demand for chemotherapy is anticipated to drive the expansion of the oncology devices market in the coming years. Chemotherapy is a cancer treatment that involves the use of potent drugs to eliminate rapidly dividing cells, thereby slowing or halting tumor growth and spread. The rising demand for chemotherapy is driven by the increasing global incidence of cancer, as a higher number of diagnosed cases leads to greater need for effective and widely available treatments capable of addressing various cancer types and stages. Oncology devices support chemotherapy by facilitating safer and more accurate drug delivery and monitoring, which improves treatment efficacy and patient outcomes. For example, in January 2025, according to the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, new cancer cases in the United States are projected to reach 2.04 million, up from 1.96 million in 2023, underscoring the growing need for chemotherapy administration systems. Therefore, the rising demand for chemotherapy is contributing to the growth of the oncology devices market.

Major companies operating in the oncology devices market are concentrating on the development of advanced, precision-oriented solutions to enhance treatment accuracy, patient safety, and clinical workflow efficiency. These innovations focus on minimally invasive technologies, improved visualization, and real-time therapy optimization to support better outcomes across a wide range of cancer types. For example, in April 2025, ZEISS, a Germany-based medical technology company, obtained FDA 510(k) clearance for its INTRABEAM 700 system, a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform intended for targeted radiation delivery in neuro-oncology and breast cancer procedures. The system provides increased precision, optimized ergonomics, and improved integration into surgical workflows, allowing clinicians to deliver localized radiation during surgery while reducing exposure to surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, enables faster clinical decision-making, and supports the industry's transition toward technologically sophisticated, patient-focused oncology care.

In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.

Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Brachytherapy Devices; Endoscopic Devices
  • 2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radition Therapy
  • 3) By End User: Hospitals; Cancer Research Institutes; Other End Users
  • Subsegments:
  • 1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)); Applicators; Seeds; Accessories
  • 2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule); Endoscopic Ultrasound Systems; Endoscopic Accessories
  • Companies Mentioned: Eckert & Ziegler BEBIG GmbH; Oncura Inc.; GE Healthcare; Medtronic plc; Varian Medical Systems Inc.; Elekta AB; Theragenics Corporation; Accuray Incorporated; Roche Diagnostics; IBA Group; Biogenex Laboratories; Becton Dickinson and Company; Siemens Healthineers; Philips Healthcare; Hologic Inc.; IBA AG; ViewRay Inc.; Canon Medical Systems Corporation; Brainlab; PerkinElmer; RaySearch Laboratories; Mevion Medical Systems; Vision RT; IsoRay; RefleXion Medical; Alpha Tau Medical; Nanobiotix; Mirada Medical Ltd.; Navidea Biopharmaceuticals Inc.
  • Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Oncology Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Oncology Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Oncology Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Oncology Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Advanced Cancer Diagnostic Devices
    • 4.2.2 Rising Use Of Image-Guided Oncology Therapies
    • 4.2.3 Growing Integration Of Minimally Invasive Cancer Treatment Tools
    • 4.2.4 Expansion Of Precision Radiation Therapy Equipment
    • 4.2.5 Enhanced Focus On Early Cancer Detection

5. Oncology Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Oncology Clinics
  • 5.4 Cancer Research Institutes
  • 5.5 Diagnostic Imaging Centers

6. Oncology Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Oncology Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Oncology Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Oncology Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Devices Market Segmentation

  • 9.1. Global Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Brachytherapy Devices, Endoscopic Devices
  • 9.2. Global Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy
  • 9.3. Global Oncology Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Cancer Research Institutes, Other End Users
  • 9.4. Global Oncology Devices Market, Sub-Segmentation Of Brachytherapy Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)), Applicators, Seeds, Accessories
  • 9.5. Global Oncology Devices Market, Sub-Segmentation Of Endoscopic Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endoscopes (Flexible, Rigid, Capsule), Endoscopic Ultrasound Systems, Endoscopic Accessories

10. Oncology Devices Market Regional And Country Analysis

  • 10.1. Global Oncology Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Oncology Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Devices Market

  • 11.1. Asia-Pacific Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Devices Market

  • 12.1. China Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Devices Market

  • 13.1. India Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Devices Market

  • 14.1. Japan Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Devices Market

  • 15.1. Australia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Devices Market

  • 16.1. Indonesia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Devices Market

  • 17.1. South Korea Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Bangladesh Oncology Devices Market

  • 18.1. Bangladesh Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Thailand Oncology Devices Market

  • 19.1. Thailand Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Vietnam Oncology Devices Market

  • 20.1. Vietnam Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Malaysia Oncology Devices Market

  • 21.1. Malaysia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Singapore Oncology Devices Market

  • 22.1. Singapore Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Philippines Oncology Devices Market

  • 23.1. Philippines Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Hong Kong Oncology Devices Market

  • 24.1. Hong Kong Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. New Zealand Oncology Devices Market

  • 25.1. New Zealand Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Taiwan Oncology Devices Market

  • 26.1. Taiwan Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Taiwan Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. South East Asia Oncology Devices Market

  • 27.1. South East Asia Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. South East Asia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Western Europe Oncology Devices Market

  • 28.1. Western Europe Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. Western Europe Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. UK Oncology Devices Market

  • 29.1. UK Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Germany Oncology Devices Market

  • 30.1. Germany Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. France Oncology Devices Market

  • 31.1. France Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Italy Oncology Devices Market

  • 32.1. Italy Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Spain Oncology Devices Market

  • 33.1. Spain Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Austria Oncology Devices Market

  • 34.1. Austria Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Belgium Oncology Devices Market

  • 35.1. Belgium Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Denmark Oncology Devices Market

  • 36.1. Denmark Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

37. Finland Oncology Devices Market

  • 37.1. Finland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

38. Ireland Oncology Devices Market

  • 38.1. Ireland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

39. Netherlands Oncology Devices Market

  • 39.1. Netherlands Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40. Norway Oncology Devices Market

  • 40.1. Norway Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

41. Portugal Oncology Devices Market

  • 41.1. Portugal Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Sweden Oncology Devices Market

  • 42.1. Sweden Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Switzerland Oncology Devices Market

  • 42.1. Switzerland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

43. Eastern Europe Oncology Devices Market

  • 43.1. Eastern Europe Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 43.2. Eastern Europe Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

44. Russia Oncology Devices Market

  • 44.1. Russia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

45. Czech Republic Oncology Devices Market

  • 45.1. Czech Republic Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

46. Poland Oncology Devices Market

  • 46.1. Poland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

47. Romania Oncology Devices Market

  • 47.1. Romania Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

48. Ukraine Oncology Devices Market

  • 48.1. Ukraine Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

49. North America Oncology Devices Market

  • 49.1. North America Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 49.2. North America Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50. USA Oncology Devices Market

  • 50.1. USA Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 50.2. USA Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

51. Canada Oncology Devices Market

  • 51.1. Canada Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 51.2. Canada Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

52. Mexico Oncology Devices Market

  • 52.1. Mexico Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 52.2. Mexico Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

53. South America Oncology Devices Market

  • 53.1. South America Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 53.2. South America Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

54. Brazil Oncology Devices Market

  • 54.1. Brazil Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

55. Chile Oncology Devices Market

  • 55.1. Chile Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

56. Argentina Oncology Devices Market

  • 56.1. Argentina Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

57. Colombia Oncology Devices Market

  • 57.1. Colombia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

58. Peru Oncology Devices Market

  • 58.1. Peru Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

59. Middle East Oncology Devices Market

  • 59.1. Middle East Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 59.2. Middle East Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

60. Saudi Arabia Oncology Devices Market

  • 60.1. Saudi Arabia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

61. Israel Oncology Devices Market

  • 61.1. Israel Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

62. Iran Oncology Devices Market

  • 62.1. Iran Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

63. Turkey Oncology Devices Market

  • 63.1. Turkey Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

64. United Arab Emirates Oncology Devices Market

  • 64.1. United Arab Emirates Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

65. Africa Oncology Devices Market

  • 65.1. Africa Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 65.2. Africa Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

66. Egypt Oncology Devices Market

  • 66.1. Egypt Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

67. Nigeria Oncology Devices Market

  • 67.1. Nigeria Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

68. South Africa Oncology Devices Market

  • 68.1. South Africa Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

69. Oncology Devices Market Regulatory and Investment Landscape

70. Oncology Devices Market Competitive Landscape And Company Profiles

  • 70.1. Oncology Devices Market Competitive Landscape And Market Share 2024
    • 70.1.1. Top 10 Companies (Ranked by revenue/share)
  • 70.2. Oncology Devices Market - Company Scoring Matrix
    • 70.2.1. Market Revenues
    • 70.2.2. Product Innovation Score
    • 70.2.3. Brand Recognition
  • 70.3. Oncology Devices Market Company Profiles
    • 70.3.1. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.2. Oncura Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

71. Oncology Devices Market Other Major And Innovative Companies

  • Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer

72. Global Oncology Devices Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The Oncology Devices Market

74. Oncology Devices Market High Potential Countries, Segments and Strategies

  • 74.1 Oncology Devices Market In 2030 - Countries Offering Most New Opportunities
  • 74.2 Oncology Devices Market In 2030 - Segments Offering Most New Opportunities
  • 74.3 Oncology Devices Market In 2030 - Growth Strategies
    • 74.3.1 Market Trend Based Strategies
    • 74.3.2 Competitor Strategies

75. Appendix

  • 75.1. Abbreviations
  • 75.2. Currencies
  • 75.3. Historic And Forecast Inflation Rates
  • 75.4. Research Inquiries
  • 75.5. The Business Research Company
  • 75.6. Copyright And Disclaimer